Lataa...
Measurement of serum PODXL concentration for detection of pancreatic cancer
BACKGROUND: The aim of this study was to investigate the use of podocalyxin (PODXL) and secretoglobin family 1D, member 2 (SCGB1D2) expressions in whole blood as diagnostic biomarkers to distinguish between patients with pancreatic cancer and control participants, in comparison with serum cancer ant...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5858829/ https://ncbi.nlm.nih.gov/pubmed/29588598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S155367 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|